| Literature DB >> 24777252 |
Luo Zhang1, Yiwu Wang2, Fengjun Xiao3, Shaoxia Wang4, Guichun Xing2, Yang Li4, Xiushan Yin2, Kefeng Lu2, Rongfei Wei2, Jiao Fan2, Yuhan Chen2, Tao Li5, Ping Xie2, Lin Yuan2, Lei Song2, Lanzhi Ma6, Lujing Ding6, Fuchu He2, Lingqiang Zhang7.
Abstract
Macrophages play pivotal roles in development, homeostasis, tissue repair and immunity. Macrophage proliferation is promoted by macrophage colony-stimulating factor (M-CSF)-induced Akt signaling; yet, how this process is terminated remains unclear. Here, we identify casein kinase 2-interacting protein-1 (CKIP-1) as a novel inhibitor of macrophage proliferation. In resting macrophages, CKIP-1 was phosphorylated at Serine 342 by constitutively active GSK3β, the downstream target of Akt. This phosphorylation triggers the polyubiquitination and proteasomal degradation of CKIP-1. Upon M-CSF stimulation, Akt is activated by CSF-1R-PI3K and then inactivates GSK3β, leading to the stabilization of CKIP-1 and β-catenin proteins. β-catenin promotes the expression of proliferation genes including cyclin D and c-Myc. CKIP-1 interacts with TRAF6, a ubiquitin ligase required for K63-linked ubiquitination and plasma membrane recruitment of Akt, and terminates TRAF6-mediated Akt activation. By this means, CKIP-1 inhibits macrophage proliferation specifically at the late stage after M-CSF stimulation. Furthermore, CKIP-1 deficiency results in increased proliferation and decreased apoptosis of macrophages in vitro and CKIP-1(-/-) mice spontaneously develop a macrophage-dominated splenomegaly and myeloproliferation. Together, these data demonstrate that CKIP-1 plays a critical role in the regulation of macrophage homeostasis by inhibiting TRAF6-mediated Akt activation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24777252 PMCID: PMC4042176 DOI: 10.1038/cr.2014.53
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617